Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betty Lamothe

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|July 12, 2008
The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKLBetty Lamothe, Alejandro D Campos, William K Webster, et al.
The Journal of Biological Chemistry|December 1, 2006
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activationBetty Lamothe, Arnaud Besse, Alejandro D Campos, et al.
Biochemical and Biophysical Research Communications|June 19, 2007
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiationBetty Lamothe, William K Webster, Ambily Gopinathan, et al.
Leukemia Research|June 14, 2025
A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosisMoshe Talpaz, Aaron T Gerds, Roger Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic LeukemiaFabiola Cervantes-Gomez, Betty Lamothe, Jennifer A Woyach, et al.
The Journal of Biological Chemistry|June 13, 2002
Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptorsAsok Mukhopadhyay, Shishir Shishodia, Jill Suttles, et al.
Gene|December 3, 2002
Partial rescue of insulin receptor-deficient mice by transgenic complementation with an activated insulin receptor in the liverAnne Baudry, Malene Jackerott, Betty Lamothe, et al.
The Journal of Biological Chemistry|December 13, 2006
TAK1-dependent signaling requires functional interaction with TAB2/TAB3Arnaud Besse, Betty Lamothe, Alejandro D Campos, et al.
Blood Cancer Journal|December 18, 2024
Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levelsGorkem Kismali, Ganiraju Manyam, Nitin Jain, et al.
Journal of Molecular Biology|January 1, 2008
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20Su-Chang Lin, Jee Y Chung, Betty Lamothe, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|July 12, 2008
The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKLBetty Lamothe, Alejandro D Campos, William K Webster, et al.
The Journal of Biological Chemistry|December 1, 2006
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activationBetty Lamothe, Arnaud Besse, Alejandro D Campos, et al.
Biochemical and Biophysical Research Communications|June 19, 2007
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiationBetty Lamothe, William K Webster, Ambily Gopinathan, et al.
Leukemia Research|June 14, 2025
A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosisMoshe Talpaz, Aaron T Gerds, Roger Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic LeukemiaFabiola Cervantes-Gomez, Betty Lamothe, Jennifer A Woyach, et al.
The Journal of Biological Chemistry|June 13, 2002
Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptorsAsok Mukhopadhyay, Shishir Shishodia, Jill Suttles, et al.
Gene|December 3, 2002
Partial rescue of insulin receptor-deficient mice by transgenic complementation with an activated insulin receptor in the liverAnne Baudry, Malene Jackerott, Betty Lamothe, et al.
The Journal of Biological Chemistry|December 13, 2006
TAK1-dependent signaling requires functional interaction with TAB2/TAB3Arnaud Besse, Betty Lamothe, Alejandro D Campos, et al.
Blood Cancer Journal|December 18, 2024
Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levelsGorkem Kismali, Ganiraju Manyam, Nitin Jain, et al.
Journal of Molecular Biology|January 1, 2008
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20Su-Chang Lin, Jee Y Chung, Betty Lamothe, et al.
Pageof 3